Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

86%

6 of 7 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 2
5(71.4%)
N/A
2(28.6%)
7Total
Phase 2(5)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)